Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-KRIT1 Antibody (R1C98)

Catalog #:   RHA14801 Specific References (15) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: WB
Accession: O00522
Overview

Catalog No.

RHA14801

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Applications

WB

Recommended Dilution

Application Dilution
WB 1:500-1:1000

Target

Krev interaction trapped protein 1, Cerebral cavernous malformations 1 protein, Krev interaction trapped 1, CCM1, KRIT1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

O00522

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1C98

Note

For research use only.

Data Image
  • Western blot
    Western blot analysis of KRIT1 in C6, 3T3, Hela, K562 lysates using KRIT1 antibody.
References

Hereditary intraosseous vascular malformation of the craniofacial region: an apparently novel disorder., PMID:11932989

KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein., PMID:12140362

KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex., PMID:15046662

CCM2 expression parallels that of CCM1., PMID:16373645

Proteomic identification of the cerebral cavernous malformation signaling complex., PMID:17900104

KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions., PMID:17954608

Ultrastructural analysis of vascular features in cerebral cavernous malformations., PMID:22776801

Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation., PMID:27548575

The CCM1-CCM2 complex controls complementary functions of ROCK1 and ROCK2 that are required for endothelial integrity., PMID:30030370

Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice., PMID:30442679

Transplacental arsenic exposure produced 5-methylcytosine methylation changes and aberrant microRNA expressions in livers of male fetal mice., PMID:32068019

Detection of p62/SQSTM1 Aggregates in Cellular Models of CCM Disease by Immunofluorescence., PMID:32524569

Fluorescence Analysis of Reactive Oxygen Species (ROS) in Cellular Models of Cerebral Cavernous Malformation Disease., PMID:32524573

β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations., PMID:36349990

Magnetic Resonance Imaging of Mouse Cerebral Cavernomas Reveal Differential Lesion Progression and Variable Permeability to Gadolinium., PMID:37078284

Datasheet

Document Download

Anti-KRIT1 Antibody (R1C98).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-KRIT1 Antibody (R1C98) [RHA14801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only